Want to join the conversation?
$EL 4Q15 Call: Sales for new products accounted for nearly 20% of our business. We launched products that resonate as strongly with consumers across the board. Emerging markets remain in major growth engines; & had become 14% of our business. Excluding China, sales in emerging markets grew 26%, with strongest performance in Brazil, Russia & Turkey.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.